Long Focus Capital Management, LLC Standard Biotools Inc. Transaction History
Long Focus Capital Management, LLC
- $2.88 Billion
- Q1 2025
A detailed history of Long Focus Capital Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 6,700,000 shares of LAB stock, worth $9.11 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
6,700,000Holding current value
$9.11 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
153Shares Held
279MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$103 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$79.8 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$29.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$23.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$14.6 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $107M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...